Search - tctmd.com

Displaying 1 - 20 of 158

Sort: Relevancy | Date

News Features

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

Shelley Wood

December 23, 2019

News Daily News

CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization

Michael O'Riordan

December 20, 2019

News Daily News

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Yael L. Maxwell

December 20, 2019

News Features

Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too

Michael O'Riordan

December 18, 2019

News Daily News

Oxygen of No Benefit, Even in MI Patients With Low-Normal Saturation

Michael O'Riordan

December 16, 2019

News Daily News

FDA Approves Icosapent Ethyl for Reducing CVD Events

Michael O'Riordan

December 13, 2019

News Daily News

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Caitlin E. Cox

December 11, 2019

News Daily News

SILVER-AMI Bests GRACE for Predicting 6-Month Mortality After Acute MI in Elderly

L.A. McKeown

December 10, 2019

News Daily News

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

L.A. McKeown

December 06, 2019

News Daily News

For Real-world ACS Patients, FFR Use in PCI Tied to Lower In-Hospital Mortality

Michael O'Riordan

December 05, 2019

News Conference News VEITH 2019

Endovascular Office-Based Labs: Balancing Upsides Against Potential for Abuse

L.A. McKeown

November 28, 2019

News Daily News

Physicians as Patients: Better Health, Less CV Prevention Among Ontario Doctors Than General Public

Yael L. Maxwell

November 26, 2019

News Conference News PCR London Valves 2019

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

Michael O'Riordan

November 25, 2019

News Conference News AHA 2019

Sex Differences, EF Thresholds Probed for Sacubitril/Valsartan in Heart Failure

Shelley Wood

November 22, 2019

News Conference News AHA 2019

Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE

Yael L. Maxwell

November 21, 2019

News Conference News AHA 2019

Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS

Todd Neale

November 20, 2019

News Daily News

VICTORIA Trial of Vericiguat for Worsening HF Meets Primary Endpoint

Todd Neale

November 20, 2019

News Conference News AHA 2019

Dapagliflozin Has Benefits Across Heart Failure Subgroups

Todd Neale

November 17, 2019

News Conference News AHA 2019

ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events

Shelley Wood

November 16, 2019

COLCOT Renews Hope for Anti-inflammatory Secondary Prevention

News Conference News AHA 2019

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

Caitlin E. Cox

November 16, 2019

Advertisement

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too

Oxygen of No Benefit, Even in MI Patients With Low-Normal Saturation

FDA Approves Icosapent Ethyl for Reducing CVD Events

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

SILVER-AMI Bests GRACE for Predicting 6-Month Mortality After Acute MI in Elderly

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

For Real-world ACS Patients, FFR Use in PCI Tied to Lower In-Hospital Mortality

Endovascular Office-Based Labs: Balancing Upsides Against Potential for Abuse

Physicians as Patients: Better Health, Less CV Prevention Among Ontario Doctors Than General Public

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

Sex Differences, EF Thresholds Probed for Sacubitril/Valsartan in Heart Failure

Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE

Some A-fib Patients May Need a Bit More Aspirin After PCI: AUGUSTUS

VICTORIA Trial of Vericiguat for Worsening HF Meets Primary Endpoint

Dapagliflozin Has Benefits Across Heart Failure Subgroups

ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content